0001104659-23-026076.txt : 20230227
0001104659-23-026076.hdr.sgml : 20230227
20230227170131
ACCESSION NUMBER: 0001104659-23-026076
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230227
DATE AS OF CHANGE: 20230227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GEMAYEL GEORGES
CENTRAL INDEX KEY: 0001256088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35518
FILM NUMBER: 23676293
MAIL ADDRESS:
STREET 1: 550 HILLS DRIVE
CITY: BEDMINSTER
STATE: NJ
ZIP: 07921
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001356576
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 301-838-2500
MAIL ADDRESS:
STREET 1: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060317
4
1
tm237737-13_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-02-23
0
0001356576
SUPERNUS PHARMACEUTICALS, INC.
SUPN
0001256088
GEMAYEL GEORGES
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE
MD
20850
1
0
0
0
Common Stock
13315
D
Director Stock Option (Right to Buy)
38.60
2023-02-23
4
A
0
6293
0
A
2033-02-23
Common Stock
6293
6293
D
Restricted Stock Units
2023-02-23
4
A
0
3886
0
A
Common Stock
3886
3886
D
The option vests on February 23, 2024.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024.
/s/ Timothy C. Dec, as attorney-in-fact
2023-02-27